跳至主要内容
临床试验/NCT07122583
NCT07122583已完成4 期

Study to Collect Post-Market Data on Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System

AbbVie1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2025年7月22日最近更新:
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
102
试验地点
1
主要终点
Number of Participants with Device and/or Procedure-Related Adverse Events (AEs)

研究概览

简要总结

The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnaires after treatment with commercial treatment parameters.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant has clearly visible fat on the submental, bilateral inner thigh or bilateral back/bra areas, which in the investigator's opinion, is appropriate for treatment with CoolSculpting Elite.
  • Participant has not had weight change exceeding 5% of body weight in the preceding month.

排除标准

  • Participant has had a recent surgical procedure in the area of intended treatment within the previous 6 months.
  • Participant has had previous surgical or invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment.
  • Participant has had a non-invasive fat reduction and/or body contouring procedure in the area of intended treatment within the previous 12 months.

研究组 & 干预措施

Cohort A: Submental

Other

Participants will receive applications of the CoolSculpting Elite System in the submental body area.

干预措施: CoolSculpting Elite System (Device)

Cohort B: Inner Thigh

Other

Participants will receive applications of the CoolSculpting Elite System in the inner thigh (bilateral) body area.

干预措施: CoolSculpting Elite System (Device)

Cohort C: Back/Bra

Other

Participants will receive applications of the CoolSculpting Elite System in the back/bra (bilateral) body area.

干预措施: CoolSculpting Elite System (Device)

结局指标

主要结局

Number of Participants with Device and/or Procedure-Related Adverse Events (AEs)

时间窗: Up to Approximately 6 Months

Frequency of device and procedure-related AEs including serious device-related adverse events (SADEs), will be analyzed per cohort.

次要结局

未报告次要终点

研究者

发起方
AbbVie
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验